Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IMMUNOCONJUGATE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Aubrey, N; Devaux, C; di Luccio, E; Goyffon, M; Rochat, H; Billiald, P
      A recombinant scFv/streptavidin-binding peptide fusion protein for the quantitative determination of the scorpion venom neurotoxin Aahl

      BIOLOGICAL CHEMISTRY
    2. Ogura, SI; Fujita, Y; Kamachi, T; Okura, I
      Preparation of chlorin e6-monoclonal antibody conjugate and its effect forphotodynamic therapy

      JOURNAL OF PORPHYRINS AND PHTHALOCYANINES
    3. Gladysheva, IP; Moroz, NA; Karmakova, TA; Nemtsova, ER; Yakubovskaya, RI; Larionova, NI
      Immunoconjugates of soybean Bowman-Birk protease inhibitor as targeted antitumor polymeric agents

      JOURNAL OF DRUG TARGETING
    4. Pietersz, GA; Sandrin, MS; Ling, S; Li, YQ; McKenzie, IFC
      LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival

      TRANSPLANT IMMUNOLOGY
    5. Remsen, LG; Marquez, C; Garcia, R; Thrun, LA; Neuwelt, EA
      Efficacy after sequencing of brain radiotherapy and enhanced antibody targeted chemotherapy delivery in a rodent human lung cancer brain xenograft model

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    6. Jaime, J; Page, M
      Paclitaxel immunoconjugate for the specific treatment of ovarian cancer invitro

      ANTICANCER RESEARCH
    7. Shiah, JG; Sun, Y; Kopeckova, P; Peterson, CM; Straight, RC; Kopecek, J
      Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates

      JOURNAL OF CONTROLLED RELEASE
    8. Antczak, C; Bauvois, B; Monneret, C; Florent, JC
      Targeting of acivicin prodrugs as antibody conjugates

      JOURNAL OF CONTROLLED RELEASE
    9. Gladysheva, IP; Polekhina, OV; Karmakova, TA; Nemtsova, ER; Yakubovskaya, RI; Shen, WC; Kennedy, AR; Larionova, NI
      Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor

      JOURNAL OF CONTROLLED RELEASE
    10. Lubic, SP; Goodwin, DA; Meares, CF; Song, C; Osen, M; Hays, M
      Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma

      JOURNAL OF NUCLEAR MEDICINE
    11. Wahl, AF; Donaldson, KL; Mixan, BJ; Trail, PA; Siegall, CB
      Selective tumor sensitization to taxanes with the MAB-drug conjugate CBR96-doxorubicin

      INTERNATIONAL JOURNAL OF CANCER
    12. D'Cruz, OJ; Uckun, FM
      Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent

      FERTILITY AND STERILITY
    13. Tommasi, M; Castelletti, D; Pasti, M; Fracasso, G; Lorenzetti, I; Sartoris, S; Pera, C; Ferrara, GB; Tridente, G; Colombatti, M
      Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    14. Bourin, P; Servat, A; Lataillade, JJ; Goyffon, M; Vaux, D; Billiald, P
      Immunolabeling of CD3-positive lymphocytes with a recombinant single-chainantibody/alkaline phosphatase conjugate

      BIOLOGICAL CHEMISTRY
    15. Zalutsky, MR; Vaidyanathan, G
      Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy

      CURRENT PHARMACEUTICAL DESIGN
    16. Kaneta, Y; Tsukazaki, K; Kubushiro, K; Sakayori, M; Ueda, M; Nozawa, S
      Selective cytotoxicity of adriamycin immunoconjugate of monoclonal antibody MSN-1 to endometrial adenocarcinoma in vitro and in vivo

      ONCOLOGY REPORTS
    17. Wakai, Y; Matsui, J; Koizumi, K; Tsunoda, S; Makimoto, H; Ohizumi, I; Taniguchi, K; Kaiho, S; Saito, H; Utoguchi, N; Tsutsumi, Y; Nakagawa, S; Ohsugi, Y; Mayumi, T
      Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23)

      JAPANESE JOURNAL OF CANCER RESEARCH
    18. Bernstein, ID
      Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate

      LEUKEMIA
    19. Funaro, A; Horenstein, AL; Santoro, P; Cinti, C; Gregorini, A; Malavasi, F
      Monoclonal antibodies and therapy of human cancers

      BIOTECHNOLOGY ADVANCES
    20. Sievers, EL
      Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    21. Yasukawa, T; Kimura, H; Tabata, Y; Miyamoto, H; Honda, Y; Ikada, Y; Ogura, Y
      Active drug targeting with immunoconjugates to choroidal neovascularization

      CURRENT EYE RESEARCH
    22. Suzawa, T; Nagamura, S; Saito, H; Ohta, S; Hanai, N; Yamasaki, M
      Synthesis and HPLC analysis of enzymatically cleavable linker consisting of poly(ethylene glycol) and dipeptide for the development of immunoconjugate

      JOURNAL OF CONTROLLED RELEASE
    23. Trieu, VN; Liu, XP; Chen, TL; Uckun, FM
      Treatment of atherosclerosis in apolipoprotein E-deficient mice with 4-(3 '-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), a potent inhibitor of triglyceride synthesis

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    24. Remsen, LG; Trail, PA; Hellstrom, I; Hellstrom, KE; Neuwelt, EA
      Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model

      NEUROSURGERY
    25. Tsunoda, S; Tsutsumi, Y; Nakagawa, S; Mayumi, T
      Targeting therapy using a monoclonal antibody against tumor vascular endothelium

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    26. Beiboer, SHW; Reurs, A; Roovers, RC; Arends, JW; Whitelegg, NR; Rees, AR; Hoogenboom, HR
      Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent

      JOURNAL OF MOLECULAR BIOLOGY
    27. Panousis, C; Pietersz, GA
      Monoclonal antibody-directed cytotoxic therapy - Potential in malignant diseases of aging

      DRUGS & AGING
    28. Uckun, FM; Messinger, Y; Chen, CL; O'Neill, K; Myers, DE; Goldman, F; Hurvitz, C; Casper, JT; Levine, A
      Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor

      CLINICAL CANCER RESEARCH
    29. Han, WR; Murray-Segal, LJ; Gershenzon, A; Zhang, JG; Hodder, AN; Pietersz, GA; Mottram, PL
      Idarubicin-145-2C11-F(ab ')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts

      TRANSPLANT IMMUNOLOGY
    30. Wang, XM; Huang, SJ
      The selective cytotoxicity of cobra venom factor immunoconjugate on cultured human nasopharyngeal carcinoma cell line

      HUMAN & EXPERIMENTAL TOXICOLOGY
    31. Melik-Nubarov, NS; Dorodnykh, TY; Batrakova, EV; Kozlov, MY; Suzdal'tseva, YG; Kabanov, AV; Alakhov, VY; Arzhakov, SA
      Synthesis and biological activity of the functional block-copolymers basedon pluronic P85-doxorubicin conjugates

      VYSOKOMOLEKULYARNYE SOEDINENIYA SERIYA A & SERIYA B
    32. McLendon, RE; Archer, GE; Larsen, RH; Akabani, G; Bigner, DD; Zalutsky, MR
      Radiotoxicity of systemically administered At-211-labeled human/mouse chimeric monoclonal antibody: A long-term survival study with histologic analysis

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    33. Sinha, AA; Quast, BJ; Reddy, PK; Elson, MK; Wilson, MJ
      Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2 '-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice

      ANTICANCER RESEARCH
    34. Dubowchik, GM; Walker, MA
      Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs

      PHARMACOLOGY & THERAPEUTICS
    35. Chen, CL; Levine, A; Rao, A; O'Neill, K; Messinger, Y; Myers, DE; Goldman, F; Hurvitz, C; Casper, JT; Uckun, FM
      Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies

      JOURNAL OF CLINICAL PHARMACOLOGY
    36. Uckun, FM; Bellomy, K; O'Neill, K; Messinger, Y; Johnson, T; Chen, CL
      Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Choumet, V; Cousin, X; Bon, C
      Production of an immunoenzymatic tracer combining a scFv and the acetylcholinesterase of Bungarus fasciatus by genetic recombination

      FEBS LETTERS
    38. Volkert, WA; Hoffman, TJ
      Therapeutic radiopharmaceuticals

      CHEMICAL REVIEWS
    39. Stan, AC; Radu, DL; Casares, S; Bona, CA; Brumeanu, TD
      Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen

      CANCER RESEARCH
    40. Tsunoda, S; Ohizumi, I; Matsui, J; Koizumi, K; Wakai, Y; Makimoto, H; Tsutsumi, Y; Utoguchi, N; Taniguchi, K; Saito, H; Harada, N; Ohsugi, Y; Mayumi, T
      Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

      BRITISH JOURNAL OF CANCER
    41. Makimoto, H; Koizumi, K; Tsunoda, S; Wakai, Y; Matsui, J; Tsutsumi, Y; Nakagawa, S; Ohizumi, I; Taniguchi, K; Saito, H; Utoguchi, N; Ohsugi, Y; Mayumi, T
      Tumor vascular targeting using a tumor-tissue endothelium-specific monoclonal antibody as an effective strategy for cancer chemotherapy

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. CHOY EHS
      CLINICAL-PHARMACOLOGY AND THERAPEUTIC POTENTIAL OF MONOCLONAL-ANTIBODY TREATMENT IN RHEUMATOID-ARTHRITIS

      Drugs & aging
    43. PIETERSZ GA; TOOHEY B; MCKENZIE IFC
      IN-VITRO AND IN-VIVO EVALUATION OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA (HTNF-ALPHA) CHEMICALLY CONJUGATED TO MONOCLONAL-ANTIBODY

      Journal of drug targeting.
    44. EK O; YANISHEVSKI Y; ZEREN T; WAURZYNIAK B; GUNTHER R; CHELSTROM L; CHANDANLANGLIE M; SCHNEIDER E; MYERS DE; EVANS W; UCKUN FM
      IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE

      Leukemia & lymphoma
    45. HARAPANHALLI RS; MATALKA KZ; JONES PL; MAHMOOD A; ADELSTEIN SJ; KASSIS AI
      LYSINE-DIRECTED CONJUGATION OF ETHIDIUM HOMODIMER TO B72.3 ANTIBODY -RETENTION OF IMMUNOREACTIVITY BUT ALTERED TUMOR TARGETING

      Nuclear medicine and biology
    46. TANAKA J; SATO E; SAITO Y; KUSANO T; KOYAMA K
      PREPARATION OF A CONJUGATE OF MITOMYCIN-C AND ANTI-NEURAL CELL-ADHESION MOLECULE MONOCLONAL-ANTIBODY FOR SPECIFIC CHEMOTHERAPY AGAINST BILIARY-TRACT CARCINOMA

      Surgery today
    47. HAISMA HJ; BRAKENHOFF RH; VANDERMEULENMUILEMAN I; PINEDO HM; BOVEN E
      CONSTRUCTION AND CHARACTERIZATION OF A FUSION PROTEIN OF SINGLE-CHAINANTI-CARCINOMA ANTIBODY 323 A3 AND HUMAN BETA-GLUCURONIDASE/

      Cancer immunology and immunotherapy
    48. YOCUM DE; SOLINGER AM; TESSER J; GLUCK O; CORNETT M; OSULLIVAN F; NORDENSSON K; DALLAIRE B; SHEN CD; LIPANI J
      CLINICAL AND IMMUNOLOGICAL EFFECTS OF A PRIMATIZED(R) ANTI-CD4 MONOCLONAL-ANTIBODY IN ACTIVE RHEUMATOID-ARTHRITIS - RESULTS OF A PHASE-I, SINGLE-DOSE, DOSE ESCALATING TRIAL

      Journal of rheumatology
    49. CHOY EHS; KINGSLEY GH; PANAYI GS
      MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS

      British journal of rheumatology
    50. SINHA AA; QUAST BJ; WILSON MJ; REDDY PK; FERNANDES ET; EWING SL; GLEASON DF
      IMMUNOCYTOCHEMICAL LOCALIZATION OF AN IMMUNOCONJUGATE (ANTIBODY IGG AGAINST PROSTATIC ACID-PHOSPHATASE CONJUGATED TO 5-FLUORO-2'-DEOXYURIDINE) IN HUMAN PROSTATE TUMORS

      Anticancer research
    51. HINMAN CL; TANG HP
      A MEMBRANE-LYTIC IMMUNOCONJUGATE SELECTIVE FOR HUMAN TUMOR T-LYMPHOCYTES

      International journal of immunopharmacology
    52. CHARI RVJ
      TARGETED DELIVERY OF CHEMOTHERAPEUTICS - TUMOR-ACTIVATED PRODRUG THERAPY

      Advanced drug delivery reviews
    53. Douillard, JY; Chatal, JF
      Monoclonal antibodies and their fragments in cancer treatment

      BULLETIN DU CANCER
    54. THAKUR ML; LI J; DONEGAN M; PALLELA VR; KOLAN H; DUGGARAJU R; MAISH D; SRIVASTAVA S
      IMPROVED ANTIBODY TARGETING WITH INTERFERON-ALPHA-2B CONJUGATE

      Journal of immunotherapy with emphasis on tumor immunology
    55. MYERS DE; JUN X; CLEMENTSON D; DONELSON R; SICHENEDER A; HOFFMAN N; BELL K; SARQUIS M; LANGLIE MC; TURNER N; UCKUN FM
      LARGE-SCALE MANUFACTURING OF TXU(ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN(PAP) IMMUNOCONJUGATE FOR CLINICAL-TRIALS

      Leukemia & lymphoma
    56. PIETERSZ GA; BOGDANOVSKI M; LI WJ
      TUMOR-ERADICATION WITH HIGH-DOSE IDARUBICIN-ANTI-LY-2.1 WITH MURINE TUMOR-NECROSIS-FACTOR-ALPHA IN MICE

      Immunology and cell biology
    57. RATHORE D; NAYAK SK; BATRA JK
      OVERPRODUCTION OF FUNGAL RIBOTOXIN ALPHA-SARCIN IN ESCHERICHIA-COLI -GENERATION OF AN ACTIVE IMMUNOTOXIN

      Gene
    58. MOSURE KW; HENDERSON AJ; KLUNK LJ; KNIPE JO
      DISPOSITION OF CONJUGATE-BOUND AND FREE DOXORUBICIN IN TUMOR-BEARING MICE FOLLOWING ADMINISTRATION OF A BR96-DOXORUBICIN IMMUNOCONJUGATE (BMS-182248)

      Cancer chemotherapy and pharmacology
    59. HEISS P; BERNATZ S; BRUCHELT G; SENEKOWITSCHSCHMIDTKE R
      CYTOTOXIC EFFECT OF IMMUNOCONJUGATE COMPOSED OF GLUCOSE-OXIDASE COUPLED TO AN ANTIGANGLIOSIDE (G(D2)) ANTIBODY ON SPHEROIDS

      Anticancer research
    60. DENARDO SJ; RICHMAN CM; GOLDSTEIN DS; SHEN S; SALAKO Q; KUKIS DL; MEARES CF; YUAN A; WELBORN JL; DENARDO GL
      YTTRIUM-90 INDIUM-111-DOTA-PEPTIDE-CHIMERIC L6 - PHARMACOKINETICS, DOSIMETRY AND INITIAL RESULTS IN PATIENTS WITH INCURABLE BREAST-CANCER/

      Anticancer research
    61. WU M
      ARE IMMUNOCONJUGATES USEFUL FOR THERAPY WITH AUTOIMMUNE-DISEASES

      International journal of immunopharmacology
    62. DOSIO F; BRUSA P; CROSASSO P; ARPICCO S; CATTEL L
      PREPARATION, CHARACTERIZATION AND PROPERTIES IN-VITRO AND IN-VIVO OF A PACLITAXEL-ALBUMIN CONJUGATE

      Journal of controlled release
    63. TRAIL PA; WILLNER D; KNIPE J; HENDERSON AJ; LASCH SJ; ZOECKLER ME; TRAILSMITH MD; DOYLE TW; KING HD; CASAZZA AM; BRASLAWSKY GR; BROWN J; HOFSTEAD SJ; GREENFIELD RS; FIRESTONE RA; MOSURE K; KADOW KF; YANG MB; HELLSTROM KE; HELLSTROM I
      EFFECT OF LINKER VARIATION ON THE STABILITY, POTENCY, AND EFFICACY OFCARCINOMA-REACTIVE BR64-DOXORUBICIN IMMUNOCONJUGATES

      Cancer research
    64. DIMASSIMO AM; DILORETO M; PACILLI A; RAUCCI G; DALATRI L; MELE A; BOLOGNESI A; POLITO L; STIRPE F; DESANTIS R
      IMMUNOCONJUGATES MADE OF AN ANTI-EGF RECEPTOR MONOCLONAL-ANTIBODY ANDTYPE-1 RIBOSOME-INACTIVATING PROTEINS FROM SAPONARIA-OCYMOIDES OR VACCARIA-PYRAMIDATA

      British Journal of Cancer
    65. JINNO H; UEDA M; ENOMOTO K; IKEDA T; KYRIAKOS P; KITAJIMA M
      EFFECTIVENESS OF AN ADRIAMYCIN IMMUNOCONJUGATE THAT RECOGNIZES THE C-ERBB-2 PRODUCT ON BREAST-CANCER CELL LIMES

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    66. NAGATA S; MASUDA K; NOGUSA H; HIRANO K; TAKAGISHI Y
      ABSENCE OF LYSOSOMAL CLEAVAGE IN THE CYTOTOXICITY MECHANISM OF AN IMMUNOCONJUGATE COMPOSED OF ANTI-ALPHA-FETOPROTEIN MONOCLONAL-ANTIBODY AND VINDESINE ANALOG

      Biological & pharmaceutical bulletin
    67. STRAND V; KEYSTONE E; BREEDVELD F
      BIOLOGIC AGENTS FOR THE TREATMENT OF RHEUMATOID-ARTHRITIS

      Rheumatic diseases clinics of North America
    68. VRIESENDORP HM; QUADRI SM; ANDERSSON BS; DICKE KA
      HEMATOLOGIC SIDE-EFFECTS OF RADIOLABELED IMMUNOGLOBULIN THERAPY

      Experimental hematology
    69. KASSIS AI; JONES PL; MATALKA KZ; ADELSTEIN SJ
      ANTIBODY-DEPENDENT SIGNAL AMPLIFICATION IN TUMOR XENOGRAFTS AFTER PRETREATMENT WITH BIOTINYLATED MONOCLONAL-ANTIBODY AND AVIDIN OR STREPTAVIDIN

      The Journal of nuclear medicine
    70. LIU CN; TADAYONI BM; BOURRET LA; MATTOCKS KM; DERR SM; WIDDISON WC; KEDERSHA NL; ARINIELLO PD; GOLDMACHER VS; LAMBERT JM; BLATTLER WA; CHARI RVJ
      ERADICATION OF LARGE COLON-TUMOR XENOGRAFTS BY TARGETED DELIVERY OF MAYTANSINOIDS

      Proceedings of the National Academy of Sciences of the United Statesof America
    71. GOFF BA; BLAKE J; BAMBERG MP; HASAN T
      TREATMENT OF OVARIAN-CANCER WITH PHOTODYNAMIC THERAPY AND IMMUNOCONJUGATES IN A MURINE OVARIAN-CANCER MODEL

      British Journal of Cancer
    72. PERRON MJ; PAGE M
      ACTIVATION OF METHOTREXATE PHENYLALANINE BY MONOCLONAL-ANTIBODY - CARBOXYPEPTIDASE-A CONJUGATE FOR THE SPECIFIC TREATMENT OF OVARIAN-CANCERIN-VITRO

      British Journal of Cancer
    73. MARTIN PJ; NELSON BJ; APPELBAUM FR; ANASETTI C; DEEG HJ; HANSEN JA; MCDONALD GB; NASH RA; SULLIVAN KM; WITHERSPOON RP; SCANNON PJ; FRIEDMANN N; STORB R
      EVALUATION OF A CD5-SPECIFIC IMMUNOTOXIN FOR TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION

      Blood
    74. SINHA AA; SACKRISON JL; DELEON OF; WILSON MJ; GLEASON DF
      ANTIBODY IMMUNOGLOBULIN-G (IGG) AGAINST HUMAN PROSTATIC SPECIFIC ANTIGEN (PSA) AS A CARRIER PROTEIN FOR CHEMOTHERAPEUTIC DRUGS TO HUMAN PROSTATE TUMORS .1. A DOUBLE IMMUNOFLUORESCENCE ANALYSIS

      The Anatomical record
    75. OBOYLE KP; COLLETTI D; MAZUREK C; WANG Y; RAY SK; DIAMOND B; ROSENBLUM MG; EPSTEIN AL; SHOCHAT D; DUTCHER JP; WIERNIK PH; KLEIN RS
      POTENTIATION OF ANTIPROLIFERATIVE EFFECTS OF MONOCLONAL-ANTIBODY LYM-1 AND IMMUNOCONJUGATE LYM-1-GELONIN ON HUMAN BURKITTS-LYMPHOMA CELLS WITH GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR

      Journal of immunotherapy with emphasis on tumor immunology
    76. MEYER DL; LAW KL; PAYNE JK; MIKOLAJCZYK SD; ZARRINMAYEH H; JUNGHEIM LN; KING JK; SHEPHERD TA; STARLING JJ
      SITE-SPECIFIC PRODRUG ACTIVATION BY ANTIBODY-BETA-LACTAMASE CONJUGATES - PRECLINICAL INVESTIGATION OF THE EFFICACY AND TOXICITY OF DOXORUBICIN DELIVERED BY ANTIBODY-DIRECTED CATALYSIS

      Bioconjugate chemistry
    77. KONDO Y; CHUNG YS; SAWADA T; INUI A; YAMASHITA Y; HIRAYAMA K; NAKATA B; HO JJL; KIM YS; SOWA M
      INTRATUMORAL INJECTION OF AN ADRIAMYCIN IMMUNOCONJUGATE AGAINST HUMANPANCREATIC-CANCER XENOGRAFTS

      Japanese journal of cancer research
    78. WILDER RB; FOWLER JF; DENARDO GL; SHEN S; WESSELS BW; DENARDO SJ
      USE OF THE LINEAR-QUADRATIC MODEL TO COMPARE DOSES DELIVERED TO THE BONE-MARROW BY I-131 LYM-1 RADIOIMMUNOTHERAPY

      Antibody immunoconjugates, and radiopharmaceuticals
    79. CHEN LG; SPALLHOLZ JE
      CYTOLYSIS OF HUMAN ERYTHROCYTES BY A COVALENT ANTIBODY-SELENIUM IMMUNOCONJUGATE

      Free radical biology & medicine
    80. BARBOUR NP; PABORJI M; ALEXANDER TC; COPPOLA WP; BOGARDUS JB
      STABILIZATION OF CHIMERIC BR96-DOXORUBICIN IMMUNOCONJUGATE

      Pharmaceutical research
    81. HOLZER U; BETHGE W; KRULL F; IHLE J; HANDGRETINGER R; REISFELD RA; DOHLSTEN M; KALLAND T; NIETHAMMER D; DANNECKER GE
      UPERANTIGEN-STAPHYLOCOCCAL-ENTEROTOXIN-A-DEPENDENT AND ANTIBODY-TARGETED LYSIS OF GD(2)-POSITIVE NEUROBLASTOMA-CELLS

      Cancer immunology and immunotherapy
    82. PIETERSZ GA; LI WJ; SUTTON VR; BURGESS J; MCKENZIE IFC; ZOLA H; TRAPANI JA
      IN-VITRO AND IN-VIVO ANTITUMOR-ACTIVITY OF A CHIMERIC ANTI-CD19 ANTIBODY

      Cancer immunology and immunotherapy
    83. CANNON GW; MARBLE DA; GRIFFITHS MM; COLE BC; MCCALL S; SCHULMAN SF; STRAND V
      IMMUNOLOGICAL ASSESSMENT DURING TREATMENT OF RHEUMATOID-ARTHRITIS WITH ANTI-CD5 IMMUNOCONJUGATE

      Journal of rheumatology
    84. LORUSSO PM; LOMEN PL; REDMAN BG; POPLIN E; BANDER JJ; VALDIVIESO M
      PHASE-I STUDY OF MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOCONJUGATE XOMAZYME-791 IN PATIENTS WITH METASTATIC COLON-CANCER

      American journal of clinical oncology
    85. TRAIL PA; WILLNER D; HELLSTROM KE
      SITE-DIRECTED DELIVERY OF ANTHRACYCLINES FOR TREATMENT OF CANCER

      Drug development research
    86. KUNG AHC; CAVAGNARO JA; MAKIN A; WHITE MA; KONG KN
      TOXICOLOGIC EVALUATIONS OF AN IMMUNOTOXIN, H65-RTA

      Fundamental and applied toxicology
    87. VUILLEZ JP
      RADIOIMMUNODETECTION IN ONCOLOGY

      La Revue de medecine interne
    88. WANG S; QUADRI SM; TANG XZ; STEPHENS LC; LOLLO CP; BARTHOLOMEW RM; VRIESENDORP HM
      LIVER TOXICITY INDUCED BY COMBINED EXTERNAL-BEAM IRRADIATION AND RADIOIMMUNOGLOBULIN THERAPY

      Radiation research
    89. DUBEL S; BREITLING F; KONTERMANN R; SCHMIDT T; SKERRA A; LITTLE M
      BIFUNCTIONAL AND MULTIMERIC COMPLEXES OF STREPTAVIDIN FUSED TO SINGLE-CHAIN ANTIBODIES (SCFV)

      Journal of immunological methods
    90. TSAI LC; CHEN YL; LEE C; CHEN HM; CHANG ZN; HUNG MW; CHAO PL; LIN JY
      GROWTH SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA IN NUDE-MICE BY MONOCLONAL-ANTIBODY C27-ABRIN A-CHAIN CONJUGATE

      Diseases of the colon & rectum
    91. SVENSSON HP; VRUDHULA VM; EMSWILER JE; MACMASTER JF; COSAND WL; SENTER PD; WALLACE PM
      IN-VITRO AND IN-VIVO ACTIVITIES OF A DOXORUBICIN PRODRUG IN COMBINATION WITH MONOCLONAL-ANTIBODY BETA-LACTAMASE CONJUGATES

      Cancer research
    92. ROWLAND AJ; MCKENZIE IFC; PIETERSZ GA
      ENHANCED ANTITUMOR EFFECTS USING A COMBINATION OF 2 ANTIBODIES CONJUGATED TO DIFFERENT DRUGS

      Journal of drug targeting.
    93. ILERCIL O; LASKE DW; WALBRIDGE S; MUASZKO K; OLDFIELD EH; YOULE RJ
      NEUROTOXICITY OF IMMUNOTOXINS

      Molecular and chemical neuropathology
    94. PAGE RL; GARG PK; VAIDYANATHAN G; ZALUTSKY MR
      PRECLINICAL EVALUATION AND PET IMAGING OF F-18 LABELED MEL-14 F(AB')(2) FRAGMENT IN NORMAL DOGS

      Nuclear medicine and biology
    95. CASAZZA AM; TRAIL PA; HELLSTROM KE
      DRUG IMMUNOTARGETING FOR CARCINOMAS - A REALITY AT LAST

      Annals of oncology
    96. SHIH LB; GOLDENBERG DM; XUAN H; LU HWZ; MATTES MJ; HALL TC
      INTERNALIZATION OF AN INTACT DOXORUBICIN IMMUNOCONJUGATE

      Cancer immunology and immunotherapy
    97. SMANS KA; HOYLAERTS MF; DEBROE ME
      REQUIREMENT OF MONOCYTES AND T-HELPER CELLS DURING DEVELOPMENT OF TUMOR-CELL CYTOTOXICITY IN TARGETED T-CELLS

      Cancer immunology and immunotherapy
    98. STRAND V; SCOTT DL; PANAYI GS
      EVALUATING BIOLOGIC AGENTS IN RHEUMATOID-ARTHRITIS - A FRAMEWORK FOR CLINICAL-TRIALS

      Journal of rheumatology
    99. FISHWILD DM; STRAND V
      ADMINISTRATION OF AN ANTI-CD5 IMMUNOCONJUGATE TO PATIENTS WITH RHEUMATOID-ARTHRITIS - EFFECT ON PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND IN-VITRO IMMUNE FUNCTION

      Journal of rheumatology
    100. LEMAISTRE CF; MENEGHETTI C; HOWES L; OSBORNE CK
      TARGETING THE EGF RECEPTOR IN BREAST-CANCER-TREATMENT

      Breast cancer research and treatment


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 01:22:52